Skip to main content
Clinical Trials/ISRCTN76324634
ISRCTN76324634CompletedNot Applicable

Adherence therapy for schizophrenia: a multi centre randomised controlled trial

Clinic of Psychiatry and Psychotherapy Bethel (Germany)0 sites160 target enrollmentStarted: February 24, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
160

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Patients between 18 and 65 years old
  • 2. Patients with schizophrenia will be enrolled when the initial acute psychotic symptoms are reduced (partial remission) from a clinical point of view so that they were able to provide a written informed consent
  • 3. Clinical diagnosis of schizophrenia will be confirmed by a research diagnosis of schizophrenia, established using the International Diagnostic Checklist for ICD-10
  • 4. Patients will be taking antipsychotic medication at the time of recruitment, and the current treating psychiatrist has recommended the individual patient to stay on antipsychotic medication for a minimum of one year.

Exclusion Criteria

  • 1. Potential study participants will be excluded if they show acute suicidal behaviours including suicidal ideas
  • 2. Insufficient German language capacities
  • 3. Are administered depot medication
  • 4. Are homeless, or suffered from a current substance or alcohol dependence (not caffeine or nicotine dependence) or mental retardation according to International Classification of Diseases (ICD-10) and Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria.
  • 5. Patients are under compulsory treatment, if they are homeless or suffer from severe medical conditions (eg. cancer, severe infection)

Investigators

Sponsor
Clinic of Psychiatry and Psychotherapy Bethel (Germany)

Similar Trials

Adherence therapy for schizophrenia | Clinical Trial